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INTRODUCTION  
 
The ends of human chromosomes (telomeres) consist of 
many  kilobases  of  the    repeating  DNA  sequence 
TTAGGG, ending in ~18 to 600 nucleotides of single-
stranded  G-rich  repeats  [1-4].  This  3’  overhang  is 
proposed to  be inserted into the double-stranded DNA, 
forming a local D-loop and an overall structure called a 
t-loop  [5,  6].  In  combination  with  the  binding  of 
telomeric proteins, this structure is thought to hide the 
ends  of  the  chromosomes  from  being  recognized  as 
double-strand  breaks  needing  repair  by  NHEJ,  which 
would form dicentric chromosomes and cause a mitotic 
catastrophe [7, 8].  
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A  combination  of  incomplete  replication,  processing 
events  and  oxidative  damage  shortens  telomeres  with 
each round of cell division. This shortening is prevented 
in  the  germline  and  certain  stem  cells  [9]  by  the 
presence  of  telomerase.  Telomerase  is  a  ribonucleo-
protein.  The  RNA  component  hTR  (hTERC)  [10] 
contains a C-rich sequence that serves as a template for 
the  addition  of  TTAGGG  repeats  using  the  reverse 
transcriptase  activity  contained  within  the  protein 
catalytic subunit hTERT [11, 12]. Telomerase activity is 
repressed  in  most  human  somatic  tissues  during 
development  [13],  leading  to  progressive  telomere 
shortening  with    subsequent  cell  divisions.  When 
telomeres become short enough to produce inadequate 
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Abstract: Endogenous genes regulated by telomere length have not previously been identified in human cells. Here we 
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that cell turnover/telomere shortening may provide a mechanism for adjusting cellular physiology. The upregulation of 
ISG15 with telomere shortening may contribute to chronic inflammatory states associated with human aging. 
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generate  a  DNA  damage  signal,  which  causes  the 
growth arrest known as senescence or replicative aging 
[8]. Many other stimuli can also induce an irreversible 
growth  arrest  which  has  historically  been  called 
senescence even though the arrest is not telomere based 
[14] .  
 
In  addition  to  protection  of  linear  chromosome  ends, 
telomeres  may  also  be  involved  in  the  regulation  of 
gene expression. The evidence comes from experiments 
in which a reporter gene inserted next to a natural or an 
artificial telomere results in  repression of expression of 
the  reporter  gene,  a  phenomenon  called  telomere 
position effect (TPE). Telomere position effect (TPE), 
first described in Drosophila, can result in the silencing 
of genes positioned next to telomeres [15, 16]. TPE has 
been  described  in  a  variety  of  organisms,  including 
Saccharomyces cerevisiae [17], Saccharomyces pombe 
[18],  Trypanosoma  brucei  [19,  20],  Plasmodium 
falciparum [21], mice [22] and humans [23, 24]. In S. 
cerevisiae,  there  appears  to  be  two  different 
mechanisms of TPE [25]. "Classical" TPE is dependent 
on the SIR family of proteins, and usually spreads in a 
continuous fashion for several kb into the subtelomeric 
region. A second mechanism involving HAST domains 
(Hda1-affected subtelomeric) influences the expression 
of  genes  ~10-25  kb  from  the  telomeres.  There  is 
evidence suggesting that both of these mechanisms may 
respond to nutrient deprivation or stress, in which relief 
of TPE contributes to the upregulation of a variety of 
subtelomeric genes (reviewed in [25]). 
 
How telomere length might regulate gene expression in 
mammals  is  completely  unknown.  The  efficiency  of 
TPE  on  model  reporters  placed  next  to  healed 
chromosomes  in  human  cells  varies  with  telomere 
length  [24].  In  contrast  to  yeast  and  parasites,  where 
telomere length is thought to be relatively constant in 
normal  cells,  telomere  length  decreases  with  age  in 
humans, raising the intriguing possibility that telomeric 
regulation  of  gene  expression  might  have  a  different   
function in mammals. Replicative senescence has been 
shown to be associated with DNA damage signals from 
"too-short" telomeres [26, 27], so there is no reason to 
suspect that TPE is involved in senescence. However, 
there is currently no demonstrated mechanism by which 
cells monitor the length of their telomeres prior to their 
becoming  short  enough  to  generate  a  DNA  damage 
signal. We have speculated that telomere length changes 
in TPE might be a mechanism for using cell turnover to 
monitoring long periods of time (years or decades) in 
order to coordinate life-history strategies in long-lived 
organisms[28].  Similarly,  length-regulated  TPE  might 
be used to change gene expression in tissues undergoing 
areas  of  chronically  increased  cell  turnover  due  to 
inflammatory  or  other  processes,  to  adjust  the 
physiological  response  over  time.  Either  of  these 
hypotheses predicts that the number of genes regulated 
by telomere length might be small, since it would not 
represent a general mechanism of gene regulation used 
during development and normal physiology but only in 
special circumstances. 
 
In  previous  studies,  reporter  genes  and  artificially 
truncated  telomeres  were  used  to  demonstrate  that 
telomere length could play a role in the repression of 
reporter  gene  expression  in  mammals  [22-24].  No 
endogenous  genes  next  to  telomeres  have  yet  been 
shown  to  be  regulated  by  telomere  length  in  human 
cells. None of 34 telomere-proximal genes were found 
to vary with telomere length when young and senescent 
human  fibroblasts  were  compared  [29].  Telomere-
proximal  genes  have  been  poorly  represented  in 
microarry chips because the complicated repeat nature 
of  the  subtelomeric  region  delayed completion of  the 
human  genome  sequence  to  the  very  ends  of  the 
chromosomes until recently. In order to perform a more 
comprehensive search for genes regulated by telomere 
length,  we  constructed  a  microarray  chip  containing 
many  newly  identified  telomere-proximal  genes.  We 
examined gene expression patterns in a variety of cell 
types in which we had manipulated telomerase in order 
to  dissociate  telomere  length  changes  from  other 
confounding factors such as time in culture and DNA 
damage  signals  from short  telomeres.  We  here  report 
the identification of ISG15 (Interferon Stimulated Gene 
15kda)  as  the  first  endogenous  human  gene  whose 
expression is regulated by telomere length. ISG15 is a 
stress-response  gene  that  may  function  as  a  tumor 
suppressor  and  contributor  to  inflammatory  responses 
[30]. This raises many intriguing issues concerning the 
role of telomere length prior to replicative arrest in the 
physiology of human aging. 
 
RESULTS 
 
Identification of Genes Up-regulated with Telomere 
Shortening 
 
Table 1 lists a panel of human fibroblasts and mammary 
epithelial cells with variations in telomere lengths used 
in  the  present  studies.  To  examine  the  correlation  of 
gene  expression  and  telomere  shortening,  we  used  a 
“Telo-Chip”, a customized microarray containing 1,323 
potential  subtelomeric  genes  (within  1,000  kilobase 
pairs from the telomeres) representing all 92 telomere 
ends. The Telo-Chip also contained 92 random control 
genes,  12  housekeeping  genes  and  198  other  genes 
(GEO  Datasets,  GSE6799).  The  initial  screen  was 
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young  cells  with  long  telomeres  (BJ-18,  HME31-26, 
and IMR90-26), cells proliferating with short telomeres 
(BJ-78,  HME31E6/7-69,  IMR90-62,  and  IMR90E6/7-
84),  and  cells  proliferating  with  experimentally 
elongated telomeres (BJ18hTERT-148, HME31hTERT-
68,  and  IMR90hTERT-134)  (Table  1).  Probes  were 
hybridized to the Telo-Chips, and data were analyzed 
with GeneSpring software. Approximately 24 genes that 
showed at least a 1.5-fold increase in all the cells with 
short  telomeres  were  further  examined  using 
quantitative PCR (q-PCR). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A major problem with previous efforts to identify TPE 
regulated  genes  is  a  failure  to  distinguish  telomere 
length  effects  from  multiple  confounding  influences, 
such  as  the  length  of  time  in  culture,  DNA  damage 
signaling  from  short  telomeres  and  clonal  succession 
[31] in heterogeneous primary cultures. Only a single 
gene, interfereon stimulated gene 15 (ISG15), met our 
criteria  for  being  regulated  by  telomere  length  when 
examined  using  the  series  of  BJ  fibroblasts  with 
different natural and manipulated telomere lengths (see 
below).  The up-regulation of  ISG15  mRNA was also 
observed in a human lung fibroblast cell line (IMR90) 
and  in  human  breast  and  kidney  epithelial  cell  lines 
(HME31  and  NHK)  with  short  telomeres  (see 
Supplementary  Figure  S1).  ISG15  is  a  ubiquitin-like 
molecule  that  can  be  conjugated  to  other  proteins 
(reviewed  in  [30,  32])  to  modify  their  function  [33]. 
Figure 1 compares the behavior of ISG15 with Agrin, 
one of many genes that failed to meet our criteria. Agrin 
is a neuronal aggregating factor [34] and was selected 
for  illustrative    purposes  because  it  is  located  just 
centromere-proximal  to  ISG15  on  chromosome 
1p36.33.  The  mRNA  levels  of  both  ISG15  and  agrin 
increase  in  human  skin  fibroblasts  as  their  telomeres 
shortened with population doublings between PD18 and 
PD83 in culture (Figure 1). 
 
 
Up-regulation  of  Agrin  Expression  is  Associated 
with  DNA  Damage  Signaling  and/or  Replicative 
Senescence 
 
As cells age, telomeres shorten and the cells eventually 
enter replicative senescence due to p53-mediated DNA 
damage signaling from the shortest telomeres [27]. This 
raised the possibility that damage signaling contributed 
to the up-regulation of gene expression we observed in 
cells  with  short  telomeres.  In  order  to  examine  this 
question,  we  elongated  the  shortest  telomeres  by 
expressing  hTERT  in  human  fibroblasts  BJ13-141. 
BJ13 is a clone in which telomerase flanked by loxP 
sites was expressed for seven doublings (beginning at 
population  doubling  (PD)  85,  approximately  five 
doublings before the parental culture senesced). After 
seven  doubling  hTERT  was  excised  by  cre-
recombinase. The preferential elongation of the shortest 
telomeres conferred an extra 50 doublings before this 
clone senesced at PD145 with a telomere length of ~4 
kb rather than the usual ~6 kb length at senescence of 
normal BJ fibroblasts [35]. We characterized the cells 
both  shortly  after  re-introducing  hTERT  (early 
expression, before significant telomere elongation had 
occurred)  and  again  ~50  doublings  later  (long-term 
expression,  after  telomeres  were  significantly 
elongated).  The  expression  of  the  senescence  marker 
Figure  1.  Up-regulation  of  gene  expression  with 
telomere shortening in human fibroblasts. mRNA levels 
of ISG15 and agrin were assayed by  qantitative PCR in human 
fibroblasts  with  different  telomere  lengths.  Results  from  at 
least three separate experiments are shown as means ± SEM. 
GAPDH  was  used  as  an  internal  normalization  control.  All 
values were then normalized to the level (=100%) of mRNA in 
young cells with long telomeres (PD18) (see Table 1). Results 
show increase of  ISG15 and agrin expression with telomere 
shortening.  Similar  results  for  ISG15  were  also  obtained  in 
IMR90  cells,  NHK  and  HME  epithelial  cells  (Supplementary 
Figure S1). 
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 SA-β  galactosidase  (Figure  2A)  and  γH2AX  DNA 
damage foci (Figure 2B) increased as cells approached 
senescence  in  both  BJ-80  and  BJ13-141  cells. 
Expressing  hTERT  rapidly  eliminated  the  SA-β-gal 
staining and reduced the γH2AX foci to the levels of 
"young" cells (Figure 2A and B), even after only six 
doublings  (BJ13-141+6H)  when  the  average  telomere 
length  was  still  close  to  that  of  the  cells  at  PD141 
(Table 1), indicating the expression of hTERT eliminated 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the DNA damage signaling and replicative senescence 
induced by short telomeres. Similarly, the expression of 
the p53 transcriptional target p21 was elevated in the 
two near senescent cell types, and its expression also 
disappeared in cells with both transient (BJ13-141+6H) 
and long-term (BJ13-141+53H) introduction of hTERT 
(Figure 2C), further confirming the inhibition of DNA 
damage  signaling  from  short  telomeres  by  the 
expression of hTERT.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Replicative senescence and DNA damage signaling independent up-regulation of ISG15 expression in cells with 
short telomeres. (A) Short and long-term expression of hTERT rescued cells from replicative senescence. BJ cells with short telomeres 
(BJ-80 and BJ13-141) exhibited significant increases in the number of SA-β-Gal positive cells; whereas, the cells with long telomeres (BJ-
18) did not show SA-β-Gal staining. Exogenous telomerase rapidly eliminated senescent cells (BJ13-141+6H, when only the shortest 
telomeres had been lengthened) as well as after bulk telomere elongation had occurred (BJ13-141+53H). Rare fields with an SA-β-Gal 
staining positive cell were selected for the last two images to validate the staining procedure. The number in each image is a key to the 
cell lines used in B-D. (B) γ-H2AX staining shows that exogenous hTERT rapidly eliminates DNA damage signalling due to short telomeres. 
Approximately 500 nuclei of each cell line were analyzed using Metasystems software (Metasystems, Germany). (C) Western blot shows 
that p21, a transcriptional target of DNA damage-induced p53 signaling, rapidly disappeared following the introduction of telomerase to 
elongate  the  shortest  telomeres.  (D)  Q-PCR  showing  that  ISG15  expression  remained  high  in  BJ  cells  rescued  from  replicative 
senescence/DNA damage signaling after only a few doublings in the presence of exogenous telomerase when telomeres were still short 
(ISG15, column 4), while elongation of the telomeres after 53 doublings led to decreased expression (ISG15, column 5). In contrast, elimi-
nating replicative senescence/DNA damage following a short exposure to telomerase caused a decrease in the expression of agrin (agrin, 
column 4). Agrin thus did not meet our criteria for telomere length regulation, since its increase in old cells (agrin, columns 2&3) is secondary 
to senescence and/or DNA damage (column 4). (E) BJ cells overexpressing hTERT and having long telomeres express low levels of ISG15.  
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Table 1. Cell lines and strains with different telomere length and telomerase activity 
 
Human Cell Lines and 
Strains  Description  TRAP
* 
Telomere 
Length 
(kb)
† 
Skin Fibroblasts       
       
BJ-18
#  PD 18
§  -  12.9 
BJ-24  PD 24  -  12.1 
BJ-50  PD 50  -  9.7 
BJ-72  PD 72  -  7.6 
BJ-83
#  PD 83  -  5.8 
BJE6/7-78  Expressing oncoproteins E6/E7 to block p53/pRB signaling, 
PD 78 
-  NA 
       
BJhTERT-168
#  Expressing hTERT, PD 168  +  13.4 
BJ18hTERT-148  Expressing hTERT, PD 148  +  10.6 
BJ13-141  Near senesence with very short telomeres, PD 141  -  4.6 
BJ13-141+6H  6 PD after introducing hTERT into BJ13-141 cells to 
remove DNA damage signaling and replicative senescence, 
still with short telomeres 
+  4.8 
BJ13-141+53H  53 PD after introducing hTERT into BJ13-141 cells, with 
elongated telomeres, PD 194 
+  6.7 
 
BJB14-411  Minimal expression of hTERT, short telomeres, PD 411  +  2.7 
BJB14-411+5H 
 
5 PD after introducing hTERT into BJB14-411 cells to 
remove DNA damage signaling and replicative senescence, 
still with short telomeres  
+  2.7 
BJB14-411+50H  50 PD after introducing hTERT into BJB14-411 cells, with 
elongated telomeres 
+  4.8 
Lung Fibroblasts       
IMR90-24.6
#  PD 24.6  -  9.9 
IMR90-61.7
#  PD 61.7  -  6.8 
IMR90E6/7-84.1
#  Expressing oncoproteins E6/E7 to block p53/pRB  
signaling, PD84.1 
-  7.2 
IMR90hTERT-124.6  Expressing hTERT, PD 124.6  +  13.3 
Mammary Epithelial 
Cells 
     
HME31-25.9
#  PD25.9  -  3.9 
HME31E/6-69.3
#  Expressing oncoproteins E6/E7 to block p53/pRB signaling, 
PD69.3 
-  2.6 
HME31hTERT-67.7
#  Expressing hTERT, PD67.7  +  3.7 
 
# Cell lines and strains used for Microarray analysis. 
* TRAP = telomeric repeat amplification protocol. + telomerase positive and – telomerase negative.  
† Telomere length was determined by Southern blot analysis (TRF). kb, kilobase, NA, not available. 
§ PD = population doublings. 
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BJ13  cells  early  and  late  after  expressing  of  hTERT. 
The mRNA level of agrin was up-regulated in cells with 
short  telomeres  (Figures  1B  and  2D).  However,  the 
expression  of  agrin  decreased  in  BJ13-141+6H  cells 
(Figure  2D),  suggesting  the  up-regulation  of  agrin  in 
cells approaching senescence was due to DNA damage 
signaling  perhaps  as  part  of    replicative  senescence. 
This pattern was typical of most of the 22 other genes 
that did not fit our criteria for co-regulation by telomere 
length. In contrast to agrin, in spite of the elimination of 
DNA  damage  signaling  and  replicative  senescence, 
ISG15 expression (mRNA in Figure 2, protein in Figure 
3)  remained  at  a  high  level  in  BJ13-141+6H  cells, 
indicating that the up-regulation of ISG15 expression in 
cells with short telomeres was not due to DNA damage 
signaling and/or replicative senescence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Telomere  Length  is  Involved  in  the  Regulation  of 
ISG15 Expression 
 
To examine the role of telomere length in the regulation 
of ISG15 expression, we cultured the BJ13-hTERT cells 
for an extended period to elongate the telomere length. 
After 53 population doublings (BJ13-hTERT+53H), the 
average  telomere  length  was  elongated  from  4.6kb 
(BJ13-141)  to  6.7kb  (Table  1).  With  telomere 
elongation, the ISG15 expression decreased to the level 
of young cells (Figure 2D, lane 5 and Figure 3A), sug-
gesting  that  ISG15  expression  is  associated  with 
telomere  length  in  human  fibroblasts.  This  is  further 
confirmed  by  the  observation  that  populations  of  BJ 
fibroblasts  overexpressing  hTERT  that  had  long 
telomeres (Table 1) expressed ISG15 at levels of young 
cells (Figure 2E and 3A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. p53 is not involved in the up-regulation of ISG15 expression in cells with short telomeres.  (A) Western blot of 
ISG15 in human fibroblasts with different telomere lengths. Both free and conjugated (data not shown) ISG15 increase with telomere 
shortening (lanes 1 and 2) and in cells with short telomere (BJ13-141 before and after expressing telomerase for 6 doublings, lanes 5 and 
6). Expression of HPV16 E6, which degrades p53, had no effect on ISG15 protein expression, while elongation of telomeres by the 
expression of telomerase for 53 doublings returned ISG15 levels to baseline. β-Actin served as a loading control. A typical result from 
three independent experiments is s shown. (B) Western bolt analysis of ISG15 and total p53 protein in young and old human fibroblasts 
with long and short telomeres, respectively. Stable expression of shRNA led to significant (> 80%) reduction in the level of p53 protein 
compared to those in parental and mock infection cells in both young and old cells. The reduction of p53 protein levels had no effect on 
the expression of ISG15. β-actin served as a loading control.  
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Up-regulation of ISG15 with Telomere Shortening is 
Independent  of  the  Expression  of  p53  and  Type  I 
Interferons 
 
ISG15 expression can be regulated by genotoxic stress 
[36-38] and type I interferons [32]. The up-regulation of 
ISG15 in the BJ fibroblast series is not associated with 
p53  expression  and  function  as  shown  by  knocking-
down the expression of p53 in both young and old BJ 
cells.  Reducing  p53  levels  had  no  effect  on  ISG15 
protein expression  (Figure 3B).  Similarly, blocking  of  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p53 functions by overexpression of E6 had no effect of 
ISG15 expression (Figure 3A, lane 4).   
 
Q-PCR  of  interferon  α  (INFA)  showed  no  change  in 
expression between young and old cells (data not shown) 
while  interferon  β1  (INFB1)  increased  (Figure  4A). 
Stably reducing INFB1 expression by ~60% in PD76 BJ 
cells  using  shRNA  produced  no  change  in  the 
expression  of  ISG15  (Figure  4B),  indicating  that  the 
increase  in  ISG15  expression  in  cells  with  short 
telomeres  is  not  a  result  of  increased  interferon 
Figure 4. The up-regulation of ISG15 expression in cells with short telomeres does not depend on interferon beta1 
(INFB1). (A) Q-PCR analysis of mRNA levels of INFB1 in human fibroblasts with different telomere length (BJ-18 to BJ-83). Results from 
at least three separate experiments are shown as means ± SEM. GAPDH was used as an internal normalization control. All values were 
then normalized to the level (=100%) of mRNA in young cells (PD18) with long telomeres. Results show an increase of INFB1 expression 
with telomere shortening. (B) Stable knock down of INFB1 by shRNA in BJ cells with short telomeres did not reduce the expression of 
ISG15. mRNA levels of ISG15 and INFB1 were quantified by q-PCR. (C) Western blot showing that blocking antibodies to both IFN α and 
β reduced the levels of both free and conjugated ISG15 in young BJ fibroblasts, but failed to reduce expression in old cells with short 
telomeres. Young (BJ-18) and old (BJ-76) cells were treated with neutralizing antibodies against INFA and INFB1. 
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 expression. This is  further confirmed by the  fact  that 
adding blocking antibodies to both INFA and INFB1 to 
the medium failed to reduce ISG15 expression in old 
cells.  However,  the  antibodies  did  reduce  ISG15 
expression in young (PD19) BJ fibroblasts (Figure 4C), 
suggesting  that  much  of  the  basal  level  of  ISG15 
expression in young cells is secondary to the interferons 
they secrete. However, the increase seen in cells with 
short  telomeres  is  controlled  by  an  independent 
mechanism other than up-regulation of type I interferon 
expression,  since  blocking  antibodies  failed  to  affect 
expression.  
 
Up-regulation of ISG15 with Aging in Human Skin 
Biopsies 
 
Significant  up-regulation  in  ISG15  protein  expression 
with  telomere  shortening  was  also  confirmed  by 
immunofluorescence  staining  (Figure  5A)  in  human 
skin  fibroblasts.  Intense  staining  was  observed  in  the 
cells with short telomeres at PD78. Since telomeres shor- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ten with in vivo aging [39], we also examined ISG15 
expression  in  human  skin  tissues  from  donors  of 
different ages (Figure 5B). The older adult group (ages 
53-68) showed a significant increase in the number of 
ISG15-positive  cells  in  the  dermis  (Figure  5C), 
indicating that up-regulation of ISG15 can occur in vivo. 
 
Expression of ISG15 is Not Regulated by "Classical" 
TPE 
 
ISG15 is located on 1p36.33, about 1M base pairs from 
the  telomere.  In  yeast,  classical  TPE  spreads  in  a 
continuous fashion from the telomere, so that all of the 
genes between a TPE silenced gene and the telomere 
would also be silenced. We examined eight other genes 
located between ISG15 and the telomere, and none of 
them showed a correlation between gene expression and 
telomere length in BJ cells (Supplementary Figure S2). 
Whether  ISG15  is  regulated  by  telomeric  looping  or 
indirectly  by  other  telomere-length  regulated  genes 
remains to be determined.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. ISG15 is increased in human skin with aging. 
(A)  Immunofluorescence  staining  of  ISG15  in  BJ  cells  at 
different  population  doublings.  The  negative  sample  was 
treated  identically  except  no  primary  antibody  was  added. 
Nuclei were stained with DAPI. Staining intensity increases in 
cells  with  short  telomeres.  (B)  Immunochemical  staining 
illustrating  an  age-dependent  up-regulation  of  ISG15 
expression in the dermis of human skin tissues. 2-4 cases were 
examined in each group. Infant, 0-1 year old; young adult, 20-
24 year old; older adult, 53-68 year old. No primary antibody 
was  added  to  the  negative  control.  (C)  Quantitation  of  the 
results of all the samples described above. 8-10 random fields 
were counted for each sample. 
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 DISCUSSION 
 
In this study, we analyzed more than 1,300 subtelomeric 
genes and open reading frames (ORFs) and another 300 
genes of interest using a customized microarray chip. 
Using young (long telomeres) and old (short telomeres) 
human  cells  we  found  genes  whose  up-regulation  is 
associated  with  DNA  damage  and  senescence  when 
telomeres  shorten,  e.g.  Agrin.  We  also  demonstrated 
that  up-regulation  of  ISG15  with  telomere  shortening 
was  not  due  to  genotoxic  stress  but  correlated  with 
telomere length, providing evidence that in addition to 
protecting linear chromosome ends, telomeres are also 
involved in the regulation of gene expression in human 
cells.  
 
ISG15  [40]  is  the  founding  member  of  a  family  of 
ubiquitin-like  modifiers  (Ubls)  that  include  SUMO, 
NEDD8 , HUB1, APG12 and APG8 [41, 42]. ISG15 
has the structure of a di-ubiquitin molecule, and the E1 
and  E2  enzymes  that  prepare  ISG15  for  conjugation 
[UBE1L  [43]  and  UBCH8/UBE2L6  [44]]  are  also 
ubiquitin-conjugating enzymes. Although there appears 
to be common pathways involving ubiquitin and ISG15, 
conjugation  does  not  increase  the  degradation  of 
ISGylated proteins [45, 46]. Although many targets of 
ISGylation  have  now  been  identified  [45],  the 
consequences  of  modification  by  ISG15  are  in  most 
cases unknown. ISG15 is able to inhibit viral release by 
blocking  the  neddylation  of  viral  assembly  proteins 
[47]. In addition, free ISG15 can be secreted [48] and 
there  is  evidence  that  it  has  cytokine-like  immuno-
modulatory properties [49-51]. 
 
There  are  three  properties  of  ISG15  that  make  it 
particularly intriguing as a gene regulated by telomere 
length. Most of the genes that are regulated in yeast by 
TPE  can  be  characterized  as  being  related  to 
stress/nutritional  deprivation  [25].  ISG15  is  expressed 
as part of the innate immunity/stress response pathway, 
and its regulation by telomere length is consistent with a 
conservation of telomeric input into the control of some 
aspects of the stress response. Secondly, secreted ISG15 
may contribute to age-related inflammation. ISG15 can 
stimulate  the  production  of  the  proinflammatory 
interferon, IFNγ, in CD3+ cells [49, 50]. Although IFNγ 
alone did not stimulate the proliferation and cytotoxicity 
of NK cells in mixed cultures with CD3+ lymphocytes, 
their  growth  and  non-MHC-restricted  killing  activity 
was greatly increased following exposure to free ISG15 
[49]. Unconjugated ISG15 is also a chemotactic factor 
for neutrophils [51]. Collectively, these results suggest 
that  secreted  ISG15  could  contribute  to  a  pro-
inflammatory  environment.  It  is  well  known  that  
inflammation is associated with a large number of age-
related  physiological  conditions,  such  as  sarcopenia 
[52],  atherosclerosis  and  cardiovascular  diseases  [53, 
54].  In  addition,  neurodegenerative  diseases  [55,  56], 
renal failure [57], osteoporosis [58], and the metabolic 
syndrome/diabetes  [59]  are  associated  with  inflam-
mation, and it has been suggested that dysregulation of 
inflammation is  a fundamental  aging mechanism  [60-
62]. 
 
 The role of replicative aging in human aging has long 
been  debated,  and  the  relatively  low  number  of 
senescent cells in tissues from elderly donors has been 
used as an argument that it is not relevant to organismal 
aging.  However,  it  is  well  established  that  telomere 
length declines with age in a large number of different 
human tissues [39]. Since ISG15 expression increases 
progressively  with  decreasing  telomere  length  before 
cells  become  senescent  (Figure  1A),  the  effects  of 
replicative aging/telomere shortening on organ function 
could also be exhibited before cells became senescent. 
 
Finally,  there  is  suggestive  evidence  that  ISG15  can 
function as a tumor suppressor [30]. Premalignant cells 
have  to  undergo  many  divisions  before  they  become 
invasive, and it is thought that the primary function of 
replicative  aging  is  to  limit  the  number  of  available 
divisions  as  a  brake  against  cancer  formation  [63]. 
Furthermore,  hyperproliferation  provides  one  of  the 
conditions favoring the development of malignancies. It 
is  possible  that  the  increased  ISG15  expression  that 
accompanies proliferation induced telomere shortening 
functions to create an internal or external environment 
that  restricts  tumor  progression.  Terminal  telomere 
shortening  has  been  viewed  as  a  "two-edged  sword", 
since in the absence of p53 very short telomeres  can 
cause  genomic  instability  and  may  contribute  to  the 
formation  of  cancer.  ISG15  regulation  may  be  one 
mechanism  by  which  telomere  shortening  suppresses 
tumor  formation  prior  to  the  telomeres  becoming 
sufficiently  short  to  cause  problems  of  genomic 
instability.  
 
At  least  five  genes  between  ISG15  and  the  telomere 
were not regulated by telomere length (Supplementary 
Figure S2). Discontinuous TPE can occur in yeast [64, 
65], and DNA looping [66] might be one mechanism 
that TPE could extend 1Mb from the telomere to the 
ISG15 gene  without controlling the expression of the 
intervening genes. Alternatively, telomere length could 
control  ISG15  indirectly  by  affecting  a  different 
telomeric  gene  that  we  have  not  yet  identified. 
Regardless  of  whether  it  is  direct  TPE  or  not,  the 
consistent change in gene expression that we observe 
when we manipulate telomeres establishes that ISG15 is 
regulated by telomere length. 
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in  this  study  is  not  unexpected.  There  are  reasons  to 
suspect cell-type specific variation in the expression of 
telomere-length co-regulated genes [67]. In the absence 
of gene regulation by telomere length cells would lack 
the ability to monitor telomere length prior to the point 
when they become so short that they generate a DNA 
damage  signal.  The  role  of  telomere  shortening  in 
monitoring  cell  turnover  or  the  passage  of  time  may 
vary  in  different  tissues.  There  may  be  many  other 
genes  that  are  tissue-specific  and  only  expressed  in 
particular cell types as a function of telomere length.  
 
The  finding  that  ISG15  expression  correlates  to  the 
telomere length in human cells suggests that telomeres 
are involved in the regulation of gene expression and 
may  be  involved  in  broader  physiological  functions 
beyond  the  protection  of  the  linear  ends  of 
chromosomes.  Shortening  of  telomeres  occurs  with 
aging both in vivo and in cell culture. It will be of great 
interest  to  explore  the  role  of  ISG15  in  tumor 
suppression  and  age-associated  inflammatory  condi-
tions,  and  finally  to  identify  additional  genes  and 
pathways  regulated  by  telomere  length  and  how  they 
impact human biology. 
 
METHODS 
 
Microarray analysis.  Microarray  analysis  was 
carried out at the UT Southwestern Medical Center at 
Dallas  DNA  Microarray  Core  Facility 
(http://microarray.swmed.edu/). Briefly, 60-70 nt oligo-
nucleotides  representing  the  selected  genes  were 
synthesized (Operon Biotechnologies, Inc.) and printed 
on  glass  slides  (Cat.  PXP-U  50B,  Full  Moon 
BioSystems,  CA).  Total  RNAs  isolated  from  human 
skin  fibroblast  (BJ-19,  BJ-78,  BJ18hTERT-148  and 
BJhTERT-168),  human  lung  fibroblasts  (IMR90-26.4, 
IMR90-61.7,  IMR90E6/7-84.1  and  IMR90hTERT-
134.6) and human mammary epithelial cells (HME31-
25.9, HME31E6/7-69.3 and HME31hTERT-67.7) were 
used  to  make  fluorescence-labeled  cRNAs  for 
hybridization by following the procedure provided by 
the  Microarray  Core  Facility  (http://microarray. 
swmed.edu/protocols/General_spotted_array. htm). The 
slides were scanned and the data were analyzed using 
GeneSpring software.  
 
Quantativite  PCR.  Quantatitive  PCR  was  carried  out 
using  the  human  Universal  Probe  Library  (Cat. 
04683633001) and TaqMan Master (Cat. 04535286001) 
from Roche following the manufacture’s manual. The 
experiments were repeated 2-3 times, and the relative 
expression  level  of  each  gene  was  normalized  to  the 
young cells with long telomeres (BJ-18, IMR90-24.6, 
and HME31-25.9). The primers and probe for each gene 
were selected by using ProbeFinder software provided 
by  Roche  (https://www.roche-applied-science.com/sis/ 
rtpcr/upl/adc.jsp). GAPDH was used as loading control. 
 
Western blot analysis. Western blot analysis was carried 
out  as  described  [68].  Monoclonal  antibody  against 
human ISG15 was generously provided by Dr. Ernest 
Borden  (Cleveland  Clinic  Foundation,  1:1,000). 
Antibody against p53 was purchased from Calbiochem 
(OP-43, 1:1,000), and antibody against ß-actin was from 
Sigma (A1978, 1:20,000).  
 
shRNAs. The retroviral-vector based shRNA construct 
against  human  p53  gene  was  provided  by  Dr.  J.D. 
Minna  (Hamon  Center  for  Therapeutic  Oncology 
Research  and  Departments  of  Internal  Medicine, 
Pharmacology,  UT  Southwestern  Medical  Center  at 
Dallas). The retroviral-vector based shRNA constructs 
against  human  INF1  gene  were  purchased  from 
OpenBiosystems (Cat. RHS1764-97198161, RHS1764-
97197488, and RHS1764-9206903). 
 
ACKNOWLEDGEMENTS 
 
This work was supported by Public Health Service grant 
AG07992 (W.E. Wright) from the National Institute on 
Aging,  and  grant  HG  000567  from  the  National 
Institutes  of  Health  and  The  W.W.  Smith  Charitable 
Trust H0506 (H. Riethman), and grant NNJ05HD36G 
from  the  National  Aeronautics  and  Space 
Administration  (J.W.Shay).  We  thank  Dr.  Ernest 
Borden (Cleveland Clinic Foundation, Cleveland, OH) 
for providing the antibody against human ISG 15. 
 
CONFLICT OF INTERESTS STATEMENT 
 
The authors declare they have no financial conflicts of 
interest. 
 
REFERENCES 
 
1.  Moyzis  RK,  Buckingham  JM,  Cram  LS,  Dani  M,  Deaven  LL, 
Jones  MD,  Meyne  J,  Ratliff  RL,  Wu  JR.  A  highly  conserved 
repetitive DNA sequence, (TTAGGG)n, present at the telomeres 
of  human  chromosomes.  Proc  Natl  Acad  Sci  U  S  A  1988;  85: 
6622-6626. 
2. Makarov VL, Hirose Y, Langmore JP. Long G tails at both ends 
of  human  chromosomes  suggest  a  C  strand  degradation 
mechanism for telomere shortening. Cell 1997; 88: 657-666. 
3. Chai W, Shay JW, Wright WE. Human telomeres maintain their 
overhang length at senescence. Mol Cell Biol 2005; 25: 2158-
2168. 
4.  Zhao  Y,  Hoshiyama  H,  Shay  JW,  Wright  WE.  Quantitative 
telomeric overhang determination using a double-strand specific 
nuclease. Nucleic Acids Res 2008; 36: e14. 
 
 
www.impactaging.com                  617                                              AGING, July 2009, Vol.1 No.7 5. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, 
Moss H, de Lange T. Mammalian telomeres end in a large duplex 
loop. Cell 1999; 97: 503-514. 
6. Murti KG, Prescott DM. Telomeres of polytene chromosomes 
in a ciliated protozoan terminate in duplex DNA loops. Proc Natl 
Acad Sci U S A 1999; 96: 14436-14439. 
7. Ferreira MG, Miller KM, Cooper JP. Indecent exposure: when 
telomeres become uncapped. Mol Cell 2004; 13: 7-18. 
8. Shay JW, Wright WE. Senescence and immortalization: role of 
telomeres and telomerase. Carcinogenesis 2005; 26: 867-874. 
9. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, 2nd, Greider CW, 
DePinho  RA.  Essential  role  of  mouse  telomerase  in  highly 
proliferative organs. Nature 1998; 392: 569-574. 
10. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, 
Adams RR, Chang E, Allsopp RC, Yu J, et al. The RNA component 
of human telomerase. Science 1995; 269: 1236-1241. 
11.  Nakamura  TM,  Morin  GB,  Chapman  KB,  Weinrich  SL, 
Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic 
subunit homologs from fission yeast and humans. Science 1997; 
277: 955-959. 
12. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, 
Caddle  SD,  Ziaugra  L,  Beijersbergen  RL,  Davidoff  MJ,  Liu  Q, 
Bacchetti S, Haber DA, Weinberg RA. hEST2, the putative human 
telomerase catalytic subunit gene, is up- regulated in tumor cells 
and during immortalization. Cell 1997; 90: 785-795. 
13.  Wright  WE,  Piatyszek  MA,  Rainey  WE,  Byrd  W,  Shay  JW. 
Telomerase activity in human germline and embryonic tissues 
and cells. Dev Genet 1996; 18: 173-179. 
14.  Itahana  K,  Campisi  J,  Dimri  GP.  Mechanisms  of  cellular 
senescence in human and mouse cells. Biogerontology 2004; 5: 
1-10. 
15. Levis R, Hazelrigg T, Rubin GM. Effects of genomic position 
on  the  expression  of  transduced  copies  of  the  white  gene  of 
Drosophila. Science 1985; 229: 558-561. 
16.  Hazelrigg  T,  Levis  R,  Rubin  GM.  Transformation  of  white 
locus  DNA  in  drosophila:  dosage  compensation,  zeste 
interaction, and position effects. Cell 1984; 36: 469-481. 
17.  Gottschling  DE,  Aparicio  OM,  Billington  BL,  Zakian  VA. 
Position effect at S. cerevisiae telomeres: reversible repression 
of Pol II transcription. Cell 1990; 63: 751-762. 
18.  Nimmo  ER,  Cranston  G,  Allshire  RC.  Telomere-associated 
chromosome  breakage  in  fission  yeast  results  in  variegated 
expression of adjacent genes. Embo J 1994; 13: 3801-3811. 
19.  Horn  D,  Cross  GA.  A  developmentally  regulated  position 
effect at a telomeric locus in Trypanosoma brucei. Cell 1995; 83: 
555-561. 
20.  Yang  X,  Figueiredo  LM,  Espinal  A,  Okubo  E,  Li  B.  RAP1  is 
essential  for  silencing  telomeric  variant  surface  glycoprotein 
genes in Trypanosoma brucei. Cell 2009; 137: 99-109. 
21. Scherf A, Hernandez-Rivas R, Buffet P, Bottius E, Benatar C, 
Pouvelle B, Gysin J, Lanzer M. Antigenic variation in malaria: in 
situ switching, relaxed and mutually  exclusive transcription  of 
var genes during intra-erythrocytic development in Plasmodium 
falciparum. Embo J 1998; 17: 5418-5426. 
22. Pedram M, Sprung CN, Gao Q, Lo AW, Reynolds GE, Murnane 
JP.  Telomere  position  effect  and  silencing  of  transgenes  near 
telomeres in the mouse. Mol Cell Biol 2006; 26: 1865-1878. 
23.  Koering  CE,  Pollice  A,  Zibella  MP,  Bauwens  S,  Puisieux  A, 
Brunori M, Brun C, Martins L, Sabatier L, Pulitzer JF, Gilson E. 
Human telomeric position effect is determined by chromosomal 
context and telomeric chromatin integrity. EMBO Rep 2002; 3: 
1055-1061. 
24.  Baur  JA,  Zou  Y,  Shay  JW,  Wright  WE.  Telomere  position 
effect in human cells. Science 2001; 292: 2075-2077. 
25. Mondoux M, Zakian VA. Telomere Position Effect: silencing 
near the end. In: de Lange T, Lundblad V, Blackburn EH, editors. 
Telomeres. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor 
Laboratory Press; 2006; 261-316. 
26. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, 
Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP. A DNA 
damage checkpoint response in telomere-initiated senescence. 
Nature 2003; 426: 194-198. 
27. Zou Y, Sfeir A, Gryaznov SM, Shay JW, Wright WE. Does a 
sentinel  or  a  subset  of  short  telomeres  determine  replicative 
senescence? Mol Biol Cell 2004; 15: 3709-3718. 
28. Wright WE, Shay JW. Time, telomeres and tumors; is cellular 
senescence more than an anticancer mechanism? Trends in Cell 
Biology 1995; 5: 293-296. 
29. Ning Y, Xu JF, Li Y, Chavez L, Riethman HC, Lansdorp PM, 
Weng  NP.  Telomere  length  and  the  expression  of  natural 
telomeric genes in human fibroblasts. Hum Mol Genet 2003; 12: 
1329-1336. 
30. Andersen JB, Hassel BA. The interferon regulated ubiquitin-
like  protein,  ISG15,  in  tumorigenesis:  friend  or  foe?  Cytokine 
Growth Factor Rev 2006; 17: 411-421. 
31. Salk D, Au K, Hoehn H, Stenchever MR, Martin GM. Evidence 
of clonal attenuation, clonal succession, and clonal expansion in 
mass  cultures  of  aging  Werner's  syndrome  skin  fibroblasts. 
Cytogenet Cell Genet 1981; 30: 108-117. 
32.  Dao  CT,  Zhang  DE.  ISG15:  a  ubiquitin-like  enigma.  Front 
Biosci 2005; 10: 2701-2722. 
33.  Okumura  F,  Zou  W,  Zhang  DE.  ISG15  modification  of  the 
eIF4E cognate 4EHP enhances cap structure-binding activity of 
4EHP. Genes Dev 2007; 21: 255-260. 
34.  Kummer  TT,  Misgeld  T,  Sanes  JR.  Assembly  of  the 
postsynaptic  membrane  at  the  neuromuscular  junction: 
paradigm lost. Curr Opin Neurobiol 2006; 16: 74-82. 
35.  Steinert  S,  Shay  JW,  Wright  WE.  Transient  expression  of 
human  telomerase  extends  the  life  span  of  normal  human 
fibroblasts.  Biochem  Biophys  Res  Commun  2000;  273:  1095-
1098. 
36. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model 
for p53-induced apoptosis. Nature 1997; 389: 300-305. 
37.  Hermeking  H,  Lengauer  C,  Polyak  K,  He  TC,  Zhang  L, 
Thiagalingam S, Kinzler KW, Vogelstein B. 14-3-3 sigma is a p53-
regulated inhibitor of G2/M progression. Mol Cell 1997; 1: 3-11. 
38. Desai SD, Mao Y, Sun M, Li TK, Wu J, Liu LF. Ubiquitin, SUMO-
1, and UCRP in camptothecin sensitivity and resistance. Ann N Y 
Acad Sci 2000; 922: 306-308. 
39. Blasco MA. Telomeres and human disease: ageing, cancer 
and beyond. Nat Rev Genet 2005; 6: 611-622. 
40. Farrell PJ, Broeze RJ, Lengyel P. Accumulation of an mRNA 
and  protein  in  interferon-treated  Ehrlich  ascites  tumour  cells. 
Nature 1979; 279: 523-525. 
41.  Schwartz DC, Hochstrasser M. A superfamily of protein tags: 
ubiquitin,  SUMO  and  related  modifiers.  Trends  Biochem  Sci 
2003; 28: 321-328. 
42. Herrmann J, Lerman LO, Lerman A. Ubiquitin and ubiquitin-
like  proteins  in  protein  regulation.  Circ  Res  2007;  100:  1276-
1291. 
 
 
www.impactaging.com                  618                                              AGING, July 2009, Vol.1 No.7 43. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape 
JM,  Silverman  RH,  Williams  BR.  Functional  classification  of 
interferon-stimulated  genes  identified  using  microarrays.  J 
Leukoc Biol 2001; 69: 912-920. 
44.  Moynihan  TP,  Ardley  HC,  Nuber  U,  Rose  SA,  Jones  PF, 
Markham  AF,  Scheffner  M,  Robinson  PA.  The  ubiquitin-
conjugating  enzymes  UbcH7  and  UbcH8  interact  with  RING 
finger/IBR motif-containing domains of HHARI and H7-AP1. J Biol 
Chem 1999; 274: 30963-30968. 
45. Malakhov MP, Kim KI, Malakhova OA, Jacobs BS, Borden EC, 
Zhang  DE.  High-throughput  immunoblotting.  Ubiquitiin-like 
protein ISG15 modifies key regulators of signal transduction. J 
Biol Chem 2003; 278: 16608-16613. 
46. Liu M, Li XL, Hassel BA. Proteasomes modulate conjugation 
to the ubiquitin-like protein, ISG15. J Biol Chem 2003; 278: 1594-
1602. 
47.  Sadler  AJ,  Williams  BR.  Interferon-inducible  antiviral 
effectors. Nat Rev Immunol 2008; 8: 559-568. 
48.  Knight  E,  Jr.,  Cordova  B.  IFN-induced  15-kDa  protein  is 
released from human lymphocytes and monocytes. J Immunol 
1991; 146: 2280-2284. 
49.  D'Cunha  J,  Knight  E,  Jr.,  Haas  AL,  Truitt  RL,  Borden  EC. 
Immunoregulatory  properties  of  ISG15,  an  interferon-induced 
cytokine. Proc Natl Acad Sci U S A 1996; 93: 211-215. 
50.  Recht  M,  Borden  EC,  Knight  E,  Jr.  A  human  15-kDa  IFN-
induced protein induces the secretion of IFN-gamma. J Immunol 
1991; 147: 2617-2623. 
51.  Owhashi  M,  Taoka  Y,  Ishii  K,  Nakazawa  S,  Uemura  H, 
Kambara H. Identification of a ubiquitin family protein as a novel 
neutrophil  chemotactic  factor.  Biochem  Biophys  Res  Commun 
2003; 309: 533-539. 
52. Roth SM, Metter EJ, Ling S, Ferrucci L. Inflammatory factors 
in age-related muscle wasting. Curr Opin Rheumatol 2006; 18: 
625-630. 
53. Grimaldi MP, Vasto S, Balistreri CR, di Carlo D, Caruso M, 
Incalcaterra  E,  Lio  D,  Caruso  C,  Candore  G.  Genetics  of 
inflammation  in  age-related  atherosclerosis:  its  relevance  to 
pharmacogenomics. Ann N Y Acad Sci 2007; 1100: 123-131. 
54.  Libby  P.  Inflammation  and  cardiovascular  disease 
mechanisms. Am J Clin Nutr 2006; 83: 456S-460S. 
55. Griffin WS. Inflammation and neurodegenerative diseases. 
Am J Clin Nutr 2006; 83: 470S-474S. 
56.  Godbout  JP,  Johnson  RW.  Age  and  neuroinflammation:  a 
lifetime  of  psychoneuroimmune  consequences.  Neurol  Clin 
2006; 24: 521-538. 
57. Csiszar A, Toth J, Peti-Peterdi J, Ungvari Z. The aging kidney: 
role  of  endothelial  oxidative  stress  and  inflammation.  Acta 
Physiol Hung 2007; 94: 107-115. 
58.  De  Martinis  M,  Di  Benedetto  MC,  Mengoli  LP,  Ginaldi  L. 
Senile osteoporosis: is it an immune-mediated disease? Inflamm 
Res 2006; 55: 399-404. 
59.  Esposito  K,  Giugliano  G,  Scuderi  N,  Giugliano  D.  Role  of 
adipokines in the obesity-inflammation relationship: the effect 
of  fat  removal.  Plast  Reconstr  Surg  2006;  118:  1048-57; 
discussion 1058-1059. 
60.  Chung  HY,  Sung  B,  Jung  KJ,  Zou  Y,  Yu  BP.  The  molecular 
inflammatory process in aging. Antioxid Redox Signal 2006; 8: 
572-581. 
61. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, 
Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani 
GC, Salvioli S. Inflammaging and anti-inflammaging: a systemic 
perspective  on  aging  and  longevity  emerged  from  studies  in 
humans. Mech Ageing Dev 2007; 128: 92-105. 
62.  Morgan  TE,  Wong  AM,  Finch  CE.  Anti-inflammatory 
mechanisms  of  dietary  restriction  in  slowing  aging  processes. 
Interdiscip Top Gerontol 2007; 35: 83-97. 
63. Shay J, Wright W. Hallmarks of telomeres in ageing research. 
J Pathol 2007; 211: 114-123. 
64. Fourel G, Revardel E, Koering CE, Gilson E. Cohabitation of 
insulators and silencing elements in yeast subtelomeric regions. 
Embo J 1999; 18: 2522-2537. 
65. Pryde FE, Louis EJ. Limitations of silencing at native yeast 
telomeres. Embo J 1999; 18: 2538-2550. 
66. Schedl P, Broach JR. Making good neighbors: the right fence 
for the right job. Nat Struct Biol 2003; 10: 241-243. 
67.  Tham  WH,  Zakian  VA.  Transcriptional  silencing  at 
Saccharomyces  telomeres:  implications  for  other  organisms. 
Oncogene 2002; 21: 512-521. 
68. Lou Z, O'Reilly S, Liang H, Maher VM, Sleight SD, McCormick 
JJ.  Down-regulation  of  overexpressed  sp1  protein  in  human 
fibrosarcoma  cell  lines  inhibits  tumor  formation.  Cancer  Res 
2005; 65: 1007-1017. 
 
 
 
 
 
www.impactaging.com                  619                                              AGING, July 2009, Vol.1 No.7 SUPPLEMENTARY FIGURES 
 
Supplementary Figure 1. ISG15 expression in other cells lines. The expression of ISG15 in other cell 
lines with long (young and hTERT expression) and short (old) telomeres. PCR reagents was analyzed by q-
PCR using probes from Roche Applied Science. The relative levels are normalized to that in young cells for 
each  cell  type.  Telomere  length  was  determined  by  Southern  blot  analysis  (TRF).  (A).  IMR  90  lung 
fibroblasts. (B). HME31 mammary epithelial cells. (C). NHK human kidney epithelial cells. 
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Supplementary Figure 2.  Expression of other 1p subtelomeric genes in BJ cells with different telomere 
lengths.  q-PCR was used to examine eight genes between ISG15 and the telomere. No signals were detected for genes 
XM_001127463, XM_926974 and XR_015286, so only five genes are shown to compare with ISG15. PCR reagents and 
probes were from Roche Applied Science. GAPDH was used as an internal normalization control. The relative levels are 
normalized  to that  in  young  BJ cells. The numbers in  parentheses indicate  the  distance of  the  gene  from the  1p 
telomere (A) ISG15 (B). NM_018948. (C). XR_015292. (D). XR_017611. (E). NM_001005484. (F). XR_017612. 
 
 
 
www.impactaging.com                  621                                              AGING, July 2009, Vol.1 No.7 
 